Hubbard Cristin's Form 4 filing
Biomarin Pharmaceutical Inc (BMRN) · filed May 6, 2025
- Accession no.
- 0001048477-25-000053
- Filed
- May 6, 2025
- Trade date
- Apr 30-May 2, 2025
- Filing delay
- 6 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $17.7K. It was filed 6 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hubbard CristinCIK 0002021836 | Officer (EVP, Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 30, 2025 | Common Stock | AGrant or awardAcquired | +273 | $54.14 | +$14,780.22 | 32,973 | Direct | |
| May 2, 2025 | Common Stock | SSaleDisposed | −273 | $64.92 | −$17,723.16 | 32,700 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.